Investigation of the anxiolytic effects of xanthohumol, a component of humulus lupulus (Hops), in the male sprague-dawley rat

AANA Journal

Volumn 81, Issue 3, 2013, Pages 193-198

  Ceremuga, Thomas E ^a   Johnson, Lori A ^a   Adams Henderson, Jamilia M ^a   McCall, Suzanne ^b   Johnson, Don ^a  

^a BAYLOR UNIVERSITY   (United States)

^b BROOKE ARMY MEDICAL CENTER   (United States)

Author keywords

Anxiolysis; Hops; Humulus lupulus; Sprague Dawley rat; Xanthohumol

Indexed keywords

FLUMAZENIL; MIDAZOLAM; XANTHOHUMOL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HUMULUS LUPULUS; MALE; NONHUMAN; OPTIMAL DRUG DOSE; RAT; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; FLAVONOIDS; HUMULUS; MALE; MAZE LEARNING; PROPIOPHENONES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A;

EID: 84881512463     PISSN: 00946354     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Anxiety and Depression Association of America. Facts & statistics. http://www.adaa.org/about-adaa/press-room/facts-statistics. Accessed April 8, 2013.
2. Reves JG, Glass PS, Lubarsky DA, McEvoy MD. Intravenous nonopioid anesthetics. In: Miller RD. Miller's Anesthesia. 6th ed. Philadelphia, PA: Elsevier Mosby; 2005:317-378.
3. Kraft M. Holistic issues in the preoperative period. Int Anesthesiol Clin. 2002;40(2):201-212.
4. Bauer KP, Dom PM, Ramirez AM, O'Flaherty JE. Preoperative intravenous midazolam: benefits beyond anxiolysis. J Clin Anesth. 2004;16(3):177-183.
5. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey [data file]. 2011. http://www.cdc.gov/ nchs/data/databriefs/db61.pdf. Accessed April 8, 2013.
6. Sabar R, Kaye AD, Frost EA. Perioperative considerations for the patient on herbal medicines. Middle East J Anesthesiol. 2001;16(3):287-314.
7. Consumer Reports. Herbal RX-the promises and pitfalls. March 1999.44-48. Cited in: Ang-Lee MK, Moss J, Yuan CS. Herbal medicines and perioperative care. JAMA. 2001;286(2):208-216.
8. The Joint Commission International. http://www.jointcommissionin ternational.org/Medication-Safety-Articles. Accessed April 8, 2013.
9. Kaye AD, Kucera I, Sabar R. Perioperative anesthesia clinical considerations of alternative medicines. Anesthesiol Clin North Am. 2004;22(1):125-139.
10. Dorman T. Herbal medicine and anesthesia. Curr Opin Anaesthesiol. 2001;14(6):667-669.
11. Lee A, Chui PT, Aun CS, Lau AS, Gin T. Incidence and risk of adverse perioperative events among surgical patients taking traditional Chinese herbal medicines. Anesthesiology. 2006;105(3):454-461.
12. Lambert C. The new ancient trend in medicine: scientific scrutiny of 'alternative' therapies. Harvard Magazine. March-April 2002. http:// harvardmagazine.com/2002/03/the-new-ancient-trend-in.html. Accessed April 8, 2013.
13. Butterweck V, Brattstroem A, Grundmann O, Koetter U. Hypothermic effects of hops are antagonized with the competitive melatonin receptor antagonist luzindole in mice. J Pharm Pharmacol. 2007;59(4):549-552.
14. Van Cleemput M, Cattoor K, De Bosscher K, Haegeman G, De Keukeleire D, Heyerick A. Hop (Humulus lupulus)-derived bitter acids as multipotent bioactive compounds. J Nat Prod. 2009;72(6):1220-1230.
15. Zanoli P, Zavatti M. Pharmacognostic and pharmacological profile of Humulus lupulus L. J Ethnopharmacol. 2008;116(3):383-396.
16. Schiller H, Forster A, Vonhoff C, Hegger M, Biller A, Winterhoff H. Sedating effects of Humulus lupulus L. extracts. Phytomedicine. 2006;13(8):535-541.
17. Aoshima H, Takeda K, Okita Y, Hossain SJ, Koda H, Kiso Y. Effects of beer and hop on ionotropic gamma-aminobutyric acid receptors. J Agric Food Chem. 2006;54(7):2514-2519.
18. Stevens JF, Page JE. Xanthohumol and related prenylflavonoids from hops and beer: to your good health! Phytochemistry. 2004;65(10): 1317-1330.
19. Gerhäuser C. Broad spectrum anti-infective potential of xanthohumol from hop (Humulus lupulus L.) in comparison with activities of other hop constituents and xanthohumol metabolites. Mol Nutr Food Res. 2005;49(9):827-831.
20. Meissner O, Häberlein H. Influence of xanthohumol on the binding behavior of GABAA receptors and their lateral mobility at hippocampal neurons. Planta Med. 2006;72(7):656-658.
21. Treit D, Menard J, Royan C. Anxiogenic stimuli in the elevated plus- maze. Pharmacol Biochem Behav. 1993;44(2):463-469.
22. Pellow S, Chopin P, File SE, Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods. 1985;14(3):149-167.
23. Montgomery KC. The relation between fear induced by novel stimulation and exploratory behavior. J Comp Physiol Psychol. 1955;48(4): 254-260.
24. Kulkarni SK, Reddy DS. Animal behavioral models for testing antianxiety agents. Methods Find Exp Clin Pharmacol. 1996;18(3):219-230.
25. Avula B, Ganzera M, Warnick JE, Feltenstein MW, Sufka KJ, Khan IA. High-performance liquid chromatographic determination of xanthohumol in rat plasma, urine, and fecal samples. J Chromatogr Sci. 2004;42(7):378-382.
26. Nutt DJ, Malizia AL. New insights into the role of the GABA(A)- benzodiazepine receptor in psychiatric disorder. Br J Psychiatry. 2001;179:390-396.
27. Hardman JG, Limbird LE, Goodman Gilman A, eds. Goodman&Gilman's The Pharmacologic Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill Professional; 2001.
28. Zanoli P, Avallone R, Baraldi M. Behavioral characterisation of the flavonoids apigenin and chrysin. Fitoterapia. 2000;71 Suppl 1:S117-123.